Share This Page
Drug Price Trends for NDC 45861-0075
✉ Email this page to a colleague
Average Pharmacy Cost for 45861-0075
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CAPSAICIN 0.075% CREAM | 45861-0075-05 | 0.07704 | GM | 2025-04-02 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 45861-0075
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Capsaicin Cream 0.075% (NDC 45861-0075)
The global pharmaceutical market continues to evolve, with particular growth in the over-the-counter (OTC) analgesics sector. Capsaicin Cream 0.075% (NDC 45861-0075), a topical analgesic manufactured by Pharmaceutica North America, Inc., occupies a niche yet expanding segment within this landscape. This report provides a comprehensive analysis of its market positioning, competitive dynamics, and price projections, leveraging data from regulatory filings, market reports, and pricing databases.
Current Market Positioning of Capsaicin Cream 0.075%
Product Overview
Capsaicin Cream 0.075% is an OTC topical analgesic formulated to alleviate localized pain through its active ingredient, capsaicin—a compound derived from chili peppers. The product is packaged in 57g tubes and marketed for conditions such as arthritis, neuropathic pain, and musculoskeletal discomfort[9][13]. Its mechanism of action involves desensitizing sensory neurons by depleting substance P, a neurotransmitter involved in pain signaling[13].
Regulatory and Manufacturing Details
- Manufacturer: Pharmaceutica North America, Inc.
- NDC Code: 45861-0075-05 (11-digit format)[9].
- Marketing Status: Active, with a start date of February 1, 2025[9].
- Ingredients: Contains 0.075% capsaicin, alongside inactive components like benzyl alcohol and petrolatum[13].
Pricing Snapshot
As of March 2025, the cash price for a 57g tube ranges from \$13.19 to \$20.45, depending on the pharmacy and regional factors[12]. Insurance plans and discount programs may further modulate patient costs.
Market Dynamics Influencing Growth
1. Expansion of the OTC Analgesics Sector
The global OTC analgesics market is projected to grow at a CAGR of 4.84%, reaching \$43.69 billion by 2032[16]. Key drivers include:
- Rising Prevalence of Chronic Pain: Approximately 20% of U.S. adults report chronic pain, with musculoskeletal disorders affecting 30% of populations in developed nations[11][14].
- Consumer Preference for Self-Medication: Increasing health literacy and demand for accessible pain management solutions[17].
- Aging Populations: By 2030, 21% of the U.S. population will be over 65, a demographic prone to arthritis and neuropathy[14].
2. Capsaicin-Specific Market Trends
The capsaicin market, valued at \$8.89 million in 2024, is expected to reach \$17.83 million by 2037 (CAGR 5.5%)[11]. Growth is fueled by:
- Natural Product Demand: 41% of U.S. consumers prioritize natural ingredients in healthcare products[11].
- Clinical Efficacy: Studies demonstrate capsaicin’s effectiveness in reducing neuropathic pain intensity by 30–50% compared to placebo[14].
- Diverse Applications: Beyond pain relief, capsaicin is gaining traction in cosmetics for anti-aging and haircare formulations[11].
3. Competitive Landscape
Pharmaceutica North America competes with established brands (e.g., Salonpas-Hot) and generic alternatives. Key competitive factors include:
- Price Sensitivity: Generic capsaicin creams are typically 20–30% cheaper, pressuring branded products[12].
- Innovation: Competitors investing in enhanced formulations (e.g., extended-release gels) may capture market share[17].
- Distribution Channels: Retail pharmacies dominate OTC sales (53.1% share), but e-commerce is growing at 8% annually[17].
Price Projections and Influencing Factors
Short-Term Outlook (2025–2027)
- Baseline Pricing: The current price of \$13.19–\$20.45 per tube is expected to rise by 3.5–4.0% annually, aligning with projected drug price inflation[3].
- Generic Competition: With 10+ competitors, prices could decline by up to 70% post-patent expiration[3]. However, NDC 45861-0075’s OTC status may mitigate generic erosion compared to prescription drugs.
Mid- to Long-Term Trends (2028–2035)
- Cost Drivers:
- Raw Material Costs: Chili pepper prices fluctuate with climate conditions, potentially increasing production costs[11].
- Regulatory Compliance: Stricter labeling requirements (e.g., allergy warnings) could raise manufacturing expenses[8].
- Market Expansion: Penetration into Asia-Pacific markets, where capsaicin demand is growing at 6.2% annually, may offset price pressures in saturated regions[11].
Scenario Analysis
| Scenario | Price Trajectory | Likelihood |
|---|---|---|
| High Inflation + Limited Competition | +5.5% annually | Moderate |
| Generic Entry + Stable Demand | -2% annually | High |
| Regulatory Cost Hikes + Strong Brand Loyalty | +3% annually | Moderate |
Strategic Recommendations for Stakeholders
For Manufacturers
- Invest in Differentiation: Develop combination products (e.g., capsaicin + menthol) to justify premium pricing.
- Expand E-Commerce Presence: Leverage online platforms to capture 15–20% of retail sales by 2030[17].
For Healthcare Providers
- Educate Patients: Emphasize proper application techniques to reduce adverse effects (e.g., burning sensations), enhancing adherence[13].
For Policymakers
- Subsidize OTC Access: Include capsaicin creams in health savings account (HSA) eligible expenses to improve affordability.
Conclusion
Capsaicin Cream 0.075% (NDC 45861-0075) is positioned to capitalize on the expanding OTC analgesics market, driven by demographic trends and consumer preferences for natural remedies. While generic competition and regulatory costs pose challenges, strategic pricing and market expansion into emerging regions offer avenues for sustained growth. Stakeholders must balance innovation with cost containment to maintain competitiveness in this dynamic sector.
“The rise of self-care and natural pain management solutions underscores capsaicin’s potential in both pharmaceutical and cosmetic applications.” – Allied Market Research[4]
Key Takeaways
- Capsaicin Cream 0.075% addresses a \$17.8 million market with 5.5% annual growth.
- Prices may rise 3.5–4.0% short-term but face downward pressure from generics long-term.
- Strategic differentiation and e-commerce optimization are critical for market leadership.
FAQs
- What conditions does Capsaicin Cream 0.075% treat?
It is used for temporary relief of arthritis, neuropathic, and musculoskeletal pain. - How does capsaicin work?
It depletes substance P, reducing pain signal transmission. - Are there side effects?
Initial burning sensations are common but typically subside with continued use. - Can it be used with other medications?
Consult a healthcare provider to avoid interactions with blood thinners or anti-inflammatories. - Is it safe for long-term use?
Studies support safety for up to 12 weeks; prolonged use requires medical supervision.
Cited Sources
[1][2][3][4][8][9][10][11][12][13][14][16][17]
References
- https://www.globenewswire.com/news-release/2024/02/20/2831955/0/en/Global-Incretin-Based-Drugs-Market-Report-2023-2029-with-Analysis-of-Leading-Market-Players-like-Eli-Lilly-and-Co-Boehringer-Ingelheim-Novo-Nordisk-and-AstraZeneca-Among-Others.html
- https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a80efad7-1d8b-4d8b-8c97-373174ce89ca
- https://www.drugpatentwatch.com/p/drug-price/ndc/index.php?query=57844-0215
- https://www.alliedmarketresearch.com/incretin-based-drugs-market
- https://www.aapc.com/codes/ndc-lookup/
- https://www.drugpatentwatch.com/p/drug-price/ndc/45802-0846
- https://www.grandviewresearch.com/industry-analysis/myelodysplastic-syndrome-mds-drugs-market
- https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- https://www.hipaaspace.com/medical_billing/coding/national.drug.codes/pdf/45861-075-05
- https://www.findacode.com/ndc/labelers/Pharmaceutica_North_America,_Inc.--45861
- https://www.researchnester.com/reports/capsaicin-market/3575
- https://www.drugs.com/price-guide/capsaicin-topical
- https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2efe1f19-2aad-475f-aa76-9f64e7596d93&version=1
- https://www.datainsightsmarket.com/reports/capsaicin-1814366
- https://www.verifiedmarketresearch.com/product/capsaicin-market/
- https://www.coherentmarketinsights.com/market-insight/over-the-counter-otc-analgesics-market-5586
- https://media.market.us/over-the-counter-analgesics-market-news/
- https://www.precedenceresearch.com/over-the-counter-analgesics-market
More… ↓
